Company: SMNR
Filing Date: 2025-08-22
Form Type: DEFA14A
Source: 0001213900-25-079507
Chunk: 33

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-22
Form: DEFA14A
Chunk 33
---
om stock” plans or any similar plan or agreement. All of the outstanding shares of capital stock of Denali are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all federal and state securities laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities. Except as disclosed in the SEC Documents, there are no stockholders agreements, voting agreements or other similar agreements with respect to Denali’s capital stock to which Denali is a party or, to the knowledge of Denali, between or among any of Denali’s stockholders. Except as disclosed in the SEC documents, there are no securities or instruments containing redemption, anti-dilution or similar provisions that will be triggered by the issuance of the Common Shares or the Business Combination.

(n) Compliance. Denali (i) is not in default under or in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by Denali under), nor has Denali received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or violation has been waived), (ii) is not in violation of any judgment, decree, or order of any court, arbitrator or other governmental authority or (iii) is not and has not been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor matters, except in each case as would not have or reasonably be expected to result in a Denali Material Adverse Effect.

(o) Litigation. There is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of Denali, threatened against or affecting Denali or any of its properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign) (collectively, an “ Action”) which (i) adversely affects or challenges the legality, validity or enforceability of any of the Denali Transaction Documents or the Common Shares or (ii) would, if there were an unfavorable